Holocene Advisors, LP Alkermes Plc. Transaction History

Holocene Advisors, LP

  • $40.7 Billion
  • Q3 2025

A detailed history of Holocene Advisors, LP transactions in Alkermes Plc. stock. As of the latest transaction made, Holocene Advisors, LP holds 2,469,030 shares of ALKS stock, worth $71.7 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,469,030
Previous 2,853,768 13.48%
Holding current value
$71.7 Million
Previous $81.6 Million 9.28%
% of portfolio
0.18%
Previous 0.21%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$26.13 - $30.46 $10.1 Million - $11.7 Million
-384,738 Reduced 13.48%
2,469,030 $74.1 Million
Q2 2025

Aug 14, 2025
BUY
$26.59 - $32.65 $18.1 Million - $22.2 Million
679,166 Added 31.23%
2,853,768 $81.6 Million
Q1 2025

May 15, 2025
BUY
$28.08 - $36.0 $53.8 Million - $69 Million
1,916,699 Added 743.19%
2,174,602 $71.8 Million
Q4 2024

Feb 14, 2025
BUY
$25.7 - $31.46 $6.63 Million - $8.11 Million
257,903 New
257,903 $7.42 Million
Q2 2023

Aug 14, 2023
SELL
$28.34 - $33.63 $42.8 Million - $50.8 Million
-1,509,196 Reduced 54.64%
1,252,953 $39.2 Million
Q1 2023

May 15, 2023
BUY
$25.31 - $29.02 $3.05 Million - $3.5 Million
120,573 Added 4.56%
2,762,149 $77.9 Million
Q4 2022

Feb 14, 2023
BUY
$21.94 - $26.24 $4.49 Million - $5.36 Million
204,439 Added 8.39%
2,641,576 $69 Million
Q3 2022

Nov 14, 2022
BUY
$22.0 - $31.87 $10.6 Million - $15.3 Million
481,630 Added 24.63%
2,437,137 $54.4 Million
Q2 2022

Aug 15, 2022
SELL
$26.4 - $30.54 $16.3 Million - $18.9 Million
-618,017 Reduced 24.01%
1,955,507 $58.3 Million
Q1 2022

May 16, 2022
SELL
$23.07 - $27.99 $9.03 Million - $11 Million
-391,268 Reduced 13.2%
2,573,524 $67.7 Million
Q4 2021

Feb 14, 2022
BUY
$21.47 - $32.08 $8.8 Million - $13.1 Million
409,816 Added 16.04%
2,964,792 $69 Million
Q3 2021

Nov 15, 2021
BUY
$23.37 - $32.13 $8.13 Million - $11.2 Million
347,979 Added 15.77%
2,554,976 $78.8 Million
Q2 2021

Aug 16, 2021
BUY
$18.78 - $25.15 $41.4 Million - $55.5 Million
2,206,997 New
2,206,997 $54.1 Million
Q2 2018

Aug 14, 2018
SELL
$40.56 - $51.36 $157,291 - $199,174
-3,878 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$53.61 - $67.26 $703,255 - $882,316
-13,118 Reduced 77.18%
3,878 $225,000
Q4 2017

Feb 14, 2018
BUY
$47.69 - $55.39 $810,539 - $941,408
16,996
16,996 $930,000

Others Institutions Holding ALKS

# of Institutions
401
Shares Held
176M
Call Options Held
901K
Put Options Held
400K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.77B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email